noom glp 1 cost expands its GLP-1 range with 'microdose' package Noom vs. Ro: Differences in

Methods We selected individuals aged 45 years and older already treated with metformin living in Lombardy, Italy, and then split them into two groups if they initiated GLP-1 RAs or other antidiabetic drugs, between 2019 and 2021

### Funding Statement SDL and AC were supported by the National Science Foundation (Grant Nos.\ CAREER DMS-1944574 and DMS-2325258) ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained

This targeted microbiome approach reflects growing research connecting gut health with metabolic balance and long-term wellness

These medications enable cause-specific management of obesity complications.

Diabetic peripheral neuropathy (DPN) is one of the complications of diabetes...

Helps maintain healthy blood sugar